Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. (Q48229800)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2003

Language	Label	Description	Also known as
English	Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.	scientific article published in October 2003

Statements

scholarly article

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. (English)

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

0 references

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Eduardo Díaz-Rubio

12

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Raquel Rodríguez-López

object named as

Raquel Rodríguez-López

9

0 references

object named as

María Torres

14

0 references

Eladio A Velasco

object named as

Eladio Velasco

10

0 references

object named as

Orland Díez

1

0 references

Miguel de la Hoya

object named as

Miguel de la Hoya

5

0 references

Ángel Carracedo

21

object named as

Angel Carracedo

1 reference

Europe PubMed Central

9 February 2018

author name string

Mercedes Durán

3

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

José Ignacio Martinez-Ferrandis

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Raquel Salazar

6

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Ana Vega

7

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Berta Campos

8

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Javier Chaves

11

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Juan Jesús Cruz

13

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Eva Esteban

15

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Andrés Cervantes

16

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Carmen Alonso

17

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Juan Manuel San Román

18

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Rogelio González-Sarmiento

19

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Cristina Miner

20

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

María Eugenia Armengod

22

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Trinidad Caldés

23

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Javier Benítez

24

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Montserrat Baiget

25

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

publication date

1 October 2003

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

22

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

301-312

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

4

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

BRCA1 Mutations and Breast Cancer in the General Population

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Mutation analysis in the BRCA2 gene in primary breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

"Other" breast cancer susceptibility genes: searching for more holy grail

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Loss of heterozygosity analysis at theBRCAloci in tumor samples from patients with familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Genetic analysis of BRCA1 function in a defined tumor cell line

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Human, canine and murine BRCA1 genes: sequence comparison among species.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

A highly accurate, low cost test for BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

21 January 2018

Spanish family study on hereditary breast and/or ovarian cancer: Analysis of theBRCA1 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10260

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HUMU.10260

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

release_m4gtqahzfbd4flsp245ojoigx4

0 references

1 reference

Europe PubMed Central

9 February 2018

http://europepmc.org/abstract/MED/12955716

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48229800&oldid=2098371760"